Faculty,Medical Oncology,Mayo Clinic
Location: United States
Roberto A. Leon Ferre, M.D., studies breast cancer with a focus on triple-negative breast cancer and immuno-oncology. Dr. Leon Ferre is interested in furthering understanding of factors that impact the prognosis and response to anti-cancer treatments in patients with breast cancer, especially immunotherapy and targeted agents. Dr. Leon Ferre is currently focused on evaluating the tumor microenvironment of patients with triple-negative breast cancer and evaluating how the presence of different immune cell populations relates to long-term outcomes and treatment response.
The ultimate goal of Dr. Leon Ferre's research is to provide a deeper understanding of the complex interactions between the immune system and breast cancer tumor cells, and leverage this understanding to design clinical trials evaluating rational combinations of novel immunotherapeutic agents, targeted therapies and cytotoxics, as well as to identify predictive biomarkers that allow for better selection of patients with breast cancer who are likely to benefit from immune-directed therapeutic strategies.
Focus areas
Significance to patient care
Dr. Leon Ferre's hope is that his research leads to the development of novel, more effective and less toxic treatments for triple-negative breast cancer. He aims to improve the length and quality of life for patients with this disease.
No Grants Mentioned !!